Coeptis Therapeutics Holdings Inc. Common Stock (COEP)
Coeptis Therapeutics Holdings Inc. (COEP) is a biotechnology company focused on developing innovative therapies for conditions with unmet medical needs. The company's mission centers on leveraging its proprietary delivery platforms and scientific expertise to advance treatments in areas such as oncology and infectious diseases. Coeptis aims to improve patient outcomes through novel medications and strategic collaborations within the pharmaceutical industry.
Company News
Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies, including Sage Therapeutics, Coeptis Therapeutics, and AvidXchange Holdings.
Law firm Monteverde & Associates is investigating potential merger issues for four companies: Coeptis Therapeutics, Regional Health Properties, Pacific Premier Bancorp, and Southport Acquisition Corporation.